Back

Galapagos N.V.

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 12 oct 2020 - 15:15
  • Statutory name Galapagos N.V.
  • Title PHASE 2B/3 TRIAL SHOWS EFFICACY OF FILGOTINIB FOR THE INDUCTION AND MAINTENANCE OF REMISSION IN MODERATELY AND SEVERELY ACTIVE ULCERATIVE COLITIS

Related downloads

202010120000000006_FASE 2B3-STUDIE TOONT WERKZAAMHEID VAN FILGOTINIB VOOR AANZET EN ONDERHOUD VAN REMISSIE BIJ MATIGE TOT ERNSTIGE ACTIEVE COLITIS ULCEROSA.pdf
202010120000000006_PHASE 2B3 TRIAL SHOWS EFFICACY OF FILGOTINIB FOR THE INDUCTION AND MAINTENANCE OF REMISSION IN MODERATELY AND SEVERELY ACTIVE ULCERATIVE COLITIS.pdf

Date last update: 27 November 2020

Share information

Share on: Share this